Untangling the link between the human gut microbiota composition and the severity of the symptoms of the COVID-19 infection.
Journal
Environmental microbiology
ISSN: 1462-2920
Titre abrégé: Environ Microbiol
Pays: England
ID NLM: 100883692
Informations de publication
Date de publication:
12 2022
12 2022
Historique:
received:
05
08
2022
accepted:
05
09
2022
pubmed:
11
9
2022
medline:
21
12
2022
entrez:
10
9
2022
Statut:
ppublish
Résumé
Recent pandemic infection caused by SARS-CoV-2 (COVID-19) led the scientific community to investigate the possible causes contributing to the physiopathology of this disease. In this context, analyses of the intestinal microbiota highlighted possible correlation between host-associated bacterial communities and development of the COVID-19. Nevertheless, a detailed investigation of the role of the human microbiota in the severity of the symptoms of this disease is still lacking. This study performed a comprehensive meta-analysis of 323 faecal samples from public and novel Italian data sets based on the shotgun metagenomic approach. In detail, the comparative analyses revealed possible differences in the microbial biodiversity related to the individual health status, highlighting a species richness decrease in COVID-19 patients with a severe prognosis. Moreover, healthy subjects resulted characterized by a higher abundance of protective and health-supporting bacterial species, while patients affected by COVID-19 disease displayed a significant increase of opportunistic pathogen bacteria involved in developing putrefactive dysbiosis. Furthermore, prediction of the microbiome functional capabilities suggested that individuals affected by COVID-19 subsist in an unbalanced metabolism characterized by an overrepresentation of enzymes involved in the protein metabolism at the expense of carbohydrates oriented pathways, which can impact on disease severity and in excessive systemic inflammation.
Identifiants
pubmed: 36086955
doi: 10.1111/1462-2920.16201
pmc: PMC9538590
doi:
Types de publication
Meta-Analysis
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
6453-6462Informations de copyright
© 2022 The Authors. Environmental Microbiology published by Society for Applied Microbiology and John Wiley & Sons Ltd.
Références
Andrade, B.G.N., Cuadrat, R.R.C., Tonetti, F.R., Kitazawa, H. & Villena, J. (2022) The role of respiratory microbiota in the protection against viral diseases: respiratory commensal bacteria as next-generation probiotics for COVID-19. Bioscience of Microbiota, Food and Health, 41, 94-102.
Baizabal-Carvallo, J.F. (2021) Gut microbiota: a potential therapeutic target for Parkinson's disease. Neural Regeneration Research, 16, 287-288.
Bohn, M.K., Hall, A., Sepiashvili, L., Jung, B., Steele, S. & Adeli, K. (2020) Pathophysiology of COVID-19: mechanisms underlying disease severity and progression. Physiology (Bethesda), 35, 288-301.
Britton, G.J., Chen-Liaw, A., Cossarini, F., Livanos, A.E., Spindler, M.P., Plitt, T. et al. (2021) Limited intestinal inflammation despite diarrhea, fecal viral RNA and SARS-CoV-2-specific IgA in patients with acute COVID-19. Scientific Reports, 11, 13308.
Brussow, H. (2021) COVID-19: vaccination problems. Environmental Microbiology, 23, 2878-2890.
Caspi, R., Billington, R., Ferrer, L., Foerster, H., Fulcher, C.A., Keseler, I.M. et al. (2016) The MetaCyc database of metabolic pathways and enzymes and the BioCyc collection of pathway/genome databases. Nucleic Acids Research, 44, D471-D480.
Chen, J., Liu, X., Liu, W., Yang, C., Jia, R., Ke, Y. et al. (2022) Comparison of the respiratory tract microbiome in hospitalized COVID-19 patients with different disease severity. Journal of Medical Virology, 94, 5284-5293.
Chen, J., Vitetta, L., Henson, J.D. & Hall, S. (2021) The intestinal microbiota and improving the efficacy of COVID-19 vaccinations. Journal of Functional Foods, 87, 104850.
Chen, Y., Ye, W., Zhang, Y. & Xu, Y. (2015) High speed BLASTN: an accelerated MegaBLAST search tool. Nucleic Acids Research, 43, 7762-7768.
Gagliardi, A., Totino, V., Cacciotti, F., Iebba, V., Neroni, B., Bonfiglio, G. et al. (2018) Rebuilding the gut microbiota ecosystem. International Journal of Environmental Research and Public Health, 15, 1679.
Hillmann, B., Al-Ghalith, G.A., Shields-Cutler, R.R., Zhu, Q., Gohl, D.M., Beckman, K.B. et al. (2018) Evaluating the information content of shallow shotgun metagenomics. mSystems, 3, e00069-e00018.
Kaur, H., Das, C. & Mande, S.S. (2017) In silico analysis of putrefaction pathways in bacteria and its implication in colorectal cancer. Frontiers in Microbiology, 8, 2166.
Kriss, M., Hazleton, K.Z., Nusbacher, N.M., Martin, C.G. & Lozupone, C.A. (2018) Low diversity gut microbiota dysbiosis: drivers, functional implications and recovery. Current Opinion in Microbiology, 44, 34-40.
Kurian, S.J., Unnikrishnan, M.K., Miraj, S.S., Bagchi, D., Banerjee, M., Reddy, B.S. et al. (2021) Probiotics in prevention and treatment of COVID-19: current perspective and future prospects. Archives of Medical Research, 52, 582-594.
Langmead, B. & Salzberg, S.L. (2012) Fast gapped-read alignment with bowtie 2. Nature Methods, 9, 357-359.
Langmead, B., Wilks, C., Antonescu, V. & Charles, R. (2019) Scaling read aligners to hundreds of threads on general-purpose processors. Bioinformatics, 35, 421-432.
Liu, Y., Zhang, H., Tang, X., Jiang, X., Yan, X., Liu, X. et al. (2021) Distinct metagenomic signatures in the SARS-CoV-2 infection. Frontiers in Cellular and Infection Microbiology, 11, 706970.
Mancabelli, L., Mancino, W., Lugli, G.A., Argentini, C., Longhi, G., Milani, C. et al. (2021) Amoxicillin-clavulanic acid resistance in the genus Bifidobacterium. Applied and Environmental Microbiology, 87, e03137-20.
Markovic, S., Rodic, A., Salom, I., Milicevic, O., Djordjevic, M. & Djordjevic, M. (2021) COVID-19 severity determinants inferred through ecological and epidemiological modeling. One Health, 13, 100355.
Masoodi, M., Peschka, M., Schmiedel, S., Haddad, M., Frye, M., Maas, C. et al. (2022) Disturbed lipid and amino acid metabolisms in COVID-19 patients. Journal of Molecular Medicine (Berlin, Germany), 100, 555-568.
Mazzarelli, A., Giancola, M.L., Farina, A., Marchioni, L., Rueca, M., Gruber, C.E.M. et al. (2021) 16S rRNA gene sequencing of rectal swab in patients affected by COVID-19. PLoS One, 16, e0247041.
McIlroy, J.R., Mullish, B.H., Goldenberg, S.D., Ianiro, G. & Marchesi, J.R. (2020) Intestinal microbiome transfer, a novel therapeutic strategy for COVID-19 induced hyperinflammation? In reply to, 'COVID-19: immunology and treatment options', Felsenstein, Herbert McNamara et al. 2020′. Clinical Immunology, 218, 108542.
Milani, C., Casey, E., Lugli, G.A., Moore, R., Kaczorowska, J., Feehily, C. et al. (2018) Tracing mother-infant transmission of bacteriophages by means of a novel analytical tool for shotgun metagenomic datasets: METAnnotatorX. Microbiome, 6, 145.
Milani, C., Lugli, G.A., Fontana, F., Mancabelli, L., Alessandri, G., Longhi, G. et al. (2021) METAnnotatorX2: a comprehensive tool for deep and shallow metagenomic data set analyses. mSystems, 6, e0058321.
Mosca, A., Leclerc, M. & Hugot, J.P. (2016) Gut microbiota diversity and human diseases: should we reintroduce key predators in our ecosystem? Frontiers in Microbiology, 7, 455.
Mosele, J.I., Macia, A. & Motilva, M.J. (2015) Metabolic and microbial modulation of the large intestine ecosystem by non-absorbed diet phenolic compounds: a review. Molecules, 20, 17429-17468.
Nguyen, Q.V., Chong, L.C., Hor, Y.Y., Lew, L.C., Rather, I.A. & Choi, S.B. (2022) Role of probiotics in the management of COVID-19: a computational perspective. Nutrients, 14, 274.
Paez-Franco, J.C., Torres-Ruiz, J., Sosa-Hernandez, V.A., Cervantes-Diaz, R., Romero-Ramirez, S., Perez-Fragoso, A. et al. (2021) Metabolomics analysis reveals a modified amino acid metabolism that correlates with altered oxygen homeostasis in COVID-19 patients. Scientific Reports, 11, 6350.
Patel, P. & Roper, J. (2021) Gut microbiome composition is associated with COVID-19 disease severity. Gastroenterology, 161, 722-724.
Rahnavard, A., Mann, B., Giri, A., Chatterjee, R. & Crandall, K.A. (2022) Metabolite, protein, and tissue dysfunction associated with COVID-19 disease severity. Scientific Reports, 12, 12204.
Romani, L., Del Chierico, F., Macari, G., Pane, S., Ristori, M.V., Guarrasi, V. et al. (2022) The relationship between pediatric gut microbiota and SARS-CoV-2 infection. Frontiers in Cellular and Infection Microbiology, 12, 908492.
Sang, J., Zhuang, D., Zhang, T., Wu, Q., Yu, J. & Zhang, Z. (2022) Convergent and divergent age patterning of gut microbiota diversity in humans and nonhuman primates. mSystems, 7, e0151221.
Sencio, V., Benech, N., Robil, C., Deruyter, L., Heumel, S., Machelart, A. et al. (2022) Alteration of the gut microbiota's composition and metabolic output correlates with COVID-19-like severity in obese NASH hamsters. Gut Microbes, 14, 2100200.
Tang, H., Bohannon, L., Lew, M., Jensen, D., Jung, S.H., Zhao, A. et al. (2021) Randomised, double-blind, placebo-controlled trial of probiotics to eliminate COVID-19 transmission in exposed household contacts (PROTECT-EHC): a clinical trial protocol. BMJ Open, 11, e047069.
Vazquez-Baeza, Y., Pirrung, M., Gonzalez, A. & Knight, R. (2013) EMPeror: a tool for visualizing high-throughput microbial community data. Gigascience, 2, 16.
Ventura, R.E., Iizumi, T., Battaglia, T., Liu, M., Perez-Perez, G.I., Herbert, J. et al. (2019) Gut microbiome of treatment-naive MS patients of different ethnicities early in disease course. Scientific Reports, 9, 16396.
Vrotsou, K., Rotaeche, R., Mateo-Abad, M., Machon, M. & Vergara, I. (2021) Variables associated with COVID-19 severity: an observational study of non-paediatric confirmed cases from the general population of the Basque Country, Spain. BMJ Open, 11, e049066.
Wang, H., Wang, H., Sun, Y., Ren, Z., Zhu, W., Li, A. et al. (2021) Potential associations between microbiome and COVID-19. Frontiers in Medicine, 8, 785496.
Wu, F., Zhao, S., Yu, B., Chen, Y.M., Wang, W., Song, Z.G. et al. (2020) A new coronavirus associated with human respiratory disease in China. Nature, 579, 265-269.
Xu, R., Lu, R., Zhang, T., Wu, Q., Cai, W., Han, X. et al. (2021) Temporal association between human upper respiratory and gut bacterial microbiomes during the course of COVID-19 in adults. Communications Biology, 4, 240.
Yarza, P., Yilmaz, P., Pruesse, E., Glockner, F.O., Ludwig, W., Schleifer, K.H. et al. (2014) Uniting the classification of cultured and uncultured bacteria and archaea using 16S rRNA gene sequences. Nature Reviews Microbiology, 12, 635-645.
Ye, Y., Choi, J.H. & Tang, H. (2011) RAPSearch: a fast protein similarity search tool for short reads. BMC Bioinformatics, 12, 159.
Yeoh, Y.K., Zuo, T., Lui, G.C., Zhang, F., Liu, Q., Li, A.Y. et al. (2021) Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut, 70, 698-706.
Zeng, M.Y., Inohara, N. & Nunez, G. (2017) Mechanisms of inflammation-driven bacterial dysbiosis in the gut. Mucosal Immunology, 10, 18-26.
Zhang, F., Wan, Y., Zuo, T., Yeoh, Y.K., Liu, Q., Zhang, L. et al. (2022) Prolonged impairment of short-chain fatty acid and L-isoleucine biosynthesis in gut microbiome in patients with COVID-19. Gastroenterology, 162(548-561), e544.
Zhao, Y., Tang, H. & Ye, Y. (2012) RAPSearch2: a fast and memory-efficient protein similarity search tool for next-generation sequencing data. Bioinformatics, 28, 125-126.
Zhou, T., Wu, J., Zeng, Y., Li, J., Yan, J., Meng, W. et al. (2022) SARS-CoV-2 triggered oxidative stress and abnormal energy metabolism in gut microbiota. MedComm, 3, e112.
Zuo, T., Zhang, F., Lui, G.C.Y., Yeoh, Y.K., Li, A.Y.L., Zhan, H. et al. (2020) Alterations in gut microbiota of patients with COVID-19 during time of hospitalization. Gastroenterology, 159(944-955), e948.